News | December 07, 2025
Paradigm Health to acquire Flatiron’s clinical research business
It's an acquisition that aims at forming one of the US's largest oncology trial networks
It's an acquisition that aims at forming one of the US's largest oncology trial networks
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
MRI is particularly valuable in pediatric care due to its non-invasive nature
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Valorum will advance the commercialization and distribution of Armlupeg in the United States
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Subscribe To Our Newsletter & Stay Updated
